Lundbeck
HLUN-B.CO
#2558
Rank
NZ$9.55 B
Marketcap
$10.04
Share price
0.05%
Change (1 day)
27.62%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.58

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.63. In 2022 the company made an earnings per share (EPS) of $0.48 a decrease over its 2021 EPS that were of $1.08.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5821.09%
2022$0.48-55.47%
2021$1.08-51.83%
2020$2.24-28.01%
2019$3.11-44.08%
2018$5.5651.94%
2017$3.66126.64%
2016$1.61-120.84%
2015-$7.755622.18%
2014-$0.14-110.03%
2013$1.35-28.08%
2012$1.88-52.1%
2011$3.92-1.31%
2010$3.9715.61%
2009$3.43